Home Page (AIDS VACCINE 2001)
Conference Mission & Sponsor
Program Committee
Program-at-a-Glance
Abstract Submission
Contact Us



Sponsor:

Foundation for AIDS Vaccine
Research and Development

Cosponsors:

US National Institutes of Health

National Institute of Allergy
and Infectious Diseases

AIDS Vaccine
Research Center

HIV Vaccine Trials Network

Office of AIDS Research

National Cancer Institute

US Centers for Disease
Control and Prevention

UNAIDS and the World
Health Organization

Agence Nationale de
Recherches sur le SIDA, France


SUBMIT ONLINE NOW

Late Breaker and Innovative Strategies Abstract

Deadline

Categories

Review Process and Presentation Opportunities

Abstract Format

Technical Submission Details

Notification and Correspondence

Abstract Withdrawals

Published Abstracts


Late Breaker and Innovative
Strategies Abstract Submissions

Abstracts that contain new data not available at the original abstract deadline may be submitted for consideration for presentation during the Late Breaker and Innovative Strategies slide session on Saturday, September 8, 2001. Only abstracts containing novel, cutting-edge will be considered. Late Breaker abstracts may be submitted on line via the Internet (www.AIDSvaccine2001.org) or as an e-mail attachment (info@AIDSvaccine2001.org). The deadline for late breaker abstract submission is August 8, 2001 at 5:30 pm EST.



Deadline

Authors should submit late breaker and innovative strategies abstracts to be received no later than 5:30 pm EDT, August 8

via the Internet: www.AIDSvaccine2001.org
or via e-mail as an MS Word document attachment:
      info@AIDSvaccine2001.org


Categories

See the Categories


Review Process and Presentation Opportunities

Abstract submissions will be reviewed by members of the Scientific Program Committee. Authors of accepted abstracts will be invited to present their work orally and/or as a poster.


Abstract Format

All abstracts should contain the following four components (please bold the four sections noted below within the text of your abstract submission):

  1. Background: a concise statement of the issue under investigation or a hypothesis;
  2. Methods: the experimental methods used (including the statistical analyses employed);
  3. Results: specific findings (promises such as "to be completed" or "to be presented" are not acceptable); and
  4. Conclusions: a summary of findings which are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included;concluding statements such as "the results will be discussed" are not acceptable).

Please do not include grant acknowledgments, literature references, or copyright or trademark symbols.


Technical Submission Details

Web Submission
E-mail Submission
See the Technical Details


Notification and Correspondence

The first notification, the Abstract Receipt Acknowledgment, will be e-mailed as soon as the abstract has been processed (up to 3 business days following receipt of e-mail attachment or approximately 30 minutes after final electronic submission via the web site). Web submitters should print and keep a copy of the receipt screen as verification of receipt. The second notification, the abstract's disposition, will be e-mailed to the corresponding author on or about August 15, 2001.


Abstract Withdrawals

Abstracts are considered official communications to the conference. For those abstracts that are accepted, submitters agree to attend the meeting and present their abstract as scheduled. Once an abstract has been accepted and scheduled, it cannot be withdrawn. The deadline for abstract withdrawal is July 10, 2001. Failure to present the scheduled abstract without prior notification of extenuating circumstances to the Conference Secretariat may result in forfeiture of attendance at future meetings.


Published Abstracts

Accepted abstracts will be published in the Program and Abstracts of the AIDS Vaccine 2001 Conference and distributed to registrants. Extra copies will be available for sale at the conference. In addition, all abstracts will be posted on the web site.

     

NCIUNAIDSWHOHVTNAVRCOARANRSNIAIDNIHCDC
Contact Us